Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study (Q41134747)
Jump to navigation
Jump to search
scientific article published on January 1, 1992
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study |
scientific article published on January 1, 1992 |
Statements
1 reference
Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study (English)
Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study (English)
1 reference
1 reference
1 reference
M. L. Citron
C. Modeas
K. Propert
M. Goutsou
1 January 1992
1 reference
1 reference
10
1 reference
3
1 reference
215-219
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference